Cellebrite DI (CLBT) Operating Income (2020 - 2025)

Cellebrite DI (CLBT) has reported Operating Income for 6 consecutive years, with $20.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Operating Income rose 32.29% year-over-year to $20.8 million; the TTM figure through Dec 2025 stood at $66.5 million (up 16.82% YoY), while the FY2025 annual figure was $66.5 million, up 16.82% from the prior year.
• Operating Income came in at $20.8 million for Q4 2025 at Cellebrite DI, up from $19.0 million in the prior quarter.
• The five-year high for Operating Income was $20.8 million in Q4 2025, with the low at -$7.6 million in Q4 2022.
• Average Operating Income over 5 years is $8.0 million, with a median of $8.7 million recorded in 2021.
• Across the five-year window, Operating Income tumbled 276.17% in 2022 and soared 6699.26% in 2024, its largest moves.
• Year by year, Operating Income stood at $4.3 million in 2021, then sank by 276.17% to -$7.6 million in 2022, then soared by 297.72% to $15.0 million in 2023, then rose by 4.85% to $15.7 million in 2024, then surged by 32.29% to $20.8 million in 2025.
• According to Business Quant data, Operating Income over the past three periods registered $20.8 million, $19.0 million, and $14.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.